Pathogenic variants in the breast cancer susceptibility gene PALB2 are associated with an approximate 53% (95% CI 44–63%) lifetime risk of developing breast cancer, increasing to 68% in those with multiple affected first-degree relatives [3]. The gene discussed is PALB2; the disease is breast carcinoma.